R Jayachandra Babu
Overview
Explore the profile of R Jayachandra Babu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neupane R, Malla S, Karthikeyan C, Asbhy Jr C, Boddu S, Jayachandra Babu R, et al.
Int J Pharm
. 2025 Feb;
673:125356.
PMID: 39956408
Drug molecules can reach intracellular targets by different mechanisms, such as passive diffusion, active transport, and endocytosis. Endocytosis is the process by which cells engulf extracellular material by forming a...
2.
Kang X, Mita N, Zhou L, Wu S, Yue Z, Jayachandra Babu R, et al.
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339264
Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for hematological cancers, yet it faces significant hurdles, particularly regarding its efficacy in solid tumors and concerning...
3.
Malla S, Nyinawabera A, Neupane R, Pathak R, Lee D, Abou-Dahech M, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123351
Apoptosis induction with taxanes or anthracyclines is the primary therapy for TNBC. Cancer cells can develop resistance to anticancer drugs, causing them to recur and metastasize. Therefore, non-apoptotic cell death...
4.
Thakur C, Karthikeyan C, Ashby Jr C, Neupane R, Singh V, Jayachandra Babu R, et al.
Front Pharmacol
. 2024 Aug;
15:1417399.
PMID: 39119607
Multiwalled carbon nanotubes (MWCNTs) are at the forefront of nanotechnology-based advancements in cancer therapy, particularly in the field of targeted drug delivery. The nanotubes are characterized by their concentric graphene...
5.
Poudel I, Mita N, Jayachandra Babu R
Expert Opin Drug Deliv
. 2024 Jul;
21(11):1595-1614.
PMID: 38993098
Introduction: 3D Printing (3DP) is an innovative fabrication technology that has gained enormous popularity through its paradigm shifts in manufacturing in several disciplines, including healthcare. In this past decade, we...
6.
Ranch K, Chawnani D, Jani H, Acharya D, Patel C, Jacob S, et al.
Expert Opin Drug Deliv
. 2024 May;
21(5):695-712.
PMID: 38787783
Introduction: Retinal drug delivery has witnessed significant advancements in recent years, mainly driven by the prevalence of retinal diseases and the need for more efficient and patient-friendly treatment strategies. Areas...
7.
Alamdari N, Aksoy B, Jayachandra Babu R, Jiang Z
Int J Biol Macromol
. 2024 May;
270(Pt 1):132298.
PMID: 38750863
Microcrystalline cellulose (MCC) is one of the essential functional excipients in the formulation of tablets. The need for cheaper MCC sources has drawn significant attention to exploring renewable sources. In...
8.
Desai D, Majrashi M, Pathak S, Almaghrabi M, Liu K, Pondugula S, et al.
Cancer Rep (Hoboken)
. 2024 Apr;
7(4):e2074.
PMID: 38627904
Background: Iatrogenesis is an inevitable global threat to healthcare that drastically increases morbidity and mortality. Cancer is a fatal pathological condition that affects people of different ages, sexes, and races...
9.
Annaji M, Mita N, Heard J, Kang X, Poudel I, Boddu S, et al.
Crit Rev Ther Drug Carrier Syst
. 2024 Apr;
41(5):111-150.
PMID: 38608134
Meloxicam, a selective COX-2 inhibitor, has demonstrated clinical effectiveness in managing inflammation and acute pain. Although available in oral and parenteral formulations such as capsule, tablet, suspension, and solution, frequent...
10.
Annaji M, Mita N, Poudel I, Boddu S, Fasina O, Jayachandra Babu R
Bioengineering (Basel)
. 2024 Mar;
11(3).
PMID: 38534533
Despite rapid progress in tissue engineering, the repair and regeneration of bone defects remains challenging, especially for non-homogenous and complicated defects. We have developed and characterized biodegradable drug-eluting scaffolds for...